| 1897 |
- Dainippon Pharmaceutical Co., Ltd., established on May 14.
- Twenty-one prominent leaders in the pharmaceutical industry in Doshomachi, Osaka, founded Osaka Pharmaceuticals Co., Ltd.
|
| 1898 |
- Pharmaceutical Plant (former Osaka Plant and former Osaka Center) established in Ebie, Osaka.
- The company acquired Dainippon Pharmaceutical Company, a public-private joint venture in Tokyo, and changed the name of the company to Dainippon Pharmaceutical Co., Ltd.
|
| 1908 |
- Osaka Pharmaceutical Testing Co., Ltd., acquired.
|
| 1914 |
- Chemical products business started.
|
| 1927 |
- EPHEDRINE "NAGAI"® (bronchodilator and antitussive) launched.
|
| 1950 |
- Veterinary drug business started.
|
| 1956 |
- OTC drug business started.
|
| 1960 |
- Food additive business established.
|
| 1962 |
- Voluntary recall of thalidomide preparation was implemented.
*Click here to see the harmful incident concerning thalidomide.
|
| 1963 |
- Dainippon Pharmaceuticals Taiwan Co., Ltd., established.
|
| 1968 |
- Suzuka Plant (Suzuka City, Mie Prefecture) established.
|
| 1970 |
- Construction of Research Laboratories (Suita City, Osaka Prefecture) completed.
|
| 1974 |
- Laboratory products business started.
|
| 1979 |
- DOLCOL® (antibacterial chemotherapy drug) launched.
|
| 1987 |
- The Japan Epilepsy Research Foundation established.
|
| 1988 |
- U.S. office opened.
- PRORENALR® (vasodilator) launched.
- CETAPRIL® (persistent ACE inhibitor depressor) launched.
|
| 1989 |
- EXCEGRAN® (antiepileptic) launched.
|
| 1993 |
- Construction of Central Distribution Center (currently, Kobe Distribution Center) completed.
|
| 1996 |
- EBASTEL® (long-acting antiallergic) launched.
|
| 1997 |
- One hundredth anniversary of founding commemorated.
|
| 1998 |
- London and Beijing offices opened.
- GASMOTIN® (gastroprokinetic) launched.
|
| 1999 |
- KADIAN® (persistent cancer pain analgesic) launched.
|
| 2002 |
- QVAR™ (inhaled steroid-based antiasthmatic) launched.
|
| 2003 |
- Osaka Plant closed (merged with Suzuka Plant)
- OPSO® (solution for treating cancer pain) launched.
|
| 2005 |
- OTC drug business transferred.
- EBASTEL® OD tablet (long-acting antiallergic) launched.
|